AI Article Synopsis

  • An 81-year-old woman with a history of kidney cancer presented with painful nodules on her lower extremities after having pulmonary nodules for years.
  • A biopsy indicated she had nodular vasculitis, and further tests suggested erythema induratum of Bazin, likely linked to tuberculosis.
  • Treatment with a standard antituberculous regimen led to significant improvement, highlighting how skin symptoms can indicate larger health issues.

Article Abstract

An 81-year-old woman with a history of renal cell carcinoma and years of slowly, progressively enlarging pulmonary nodules of uncertain etiology presented with several weeks of painful lower extremity nodules. A biopsy revealed changes consistent with nodular vasculitis. A purified protein derivative and QuantiFERON test were positive, favoring the diagnosis of erythema induratum of Bazin. Treatment with a standard four-drug antituberculous regimen resulted in radiographic and clinical improvement. This case emphasizes the importance of dermatologic manifestations in the detection of systemic disease.

Download full-text PDF

Source

Publication Analysis

Top Keywords

erythema induratum
8
induratum bazin
8
bazin 81-year-old
4
81-year-old woman
4
woman history
4
history renal
4
renal cell
4
cell carcinoma
4
carcinoma years
4
years slowly
4

Similar Publications

Erythema induratum of Bazin (EIB) is a rare manifestation of cutaneous tuberculosis, typically associated with active tuberculosis infections. We present the case of a 75-year-old immunocompetent Spanish woman who developed nodular lesions on her lower limbs. Initial differential diagnoses included sporotrichosis, erythema nodosum, Sweet's syndrome, sarcoidosis, and tuberculosis.

View Article and Find Full Text PDF

Introduction: Nodular vasculitis (NV) is a rare form of panniculitis primarily affecting middle-aged females, presenting as painful, sometimes ulcerated nodules on the dorsal lower legs. Erythema induratum of Bazin (EIB) is a form of NV and is considered a manifestation of cutaneous tuberculin hypersensitivity. This retrospective study aims to analyze demographics, clinicopathological findings, laboratory results, and treatment outcomes of NV in a non-TB endemic country.

View Article and Find Full Text PDF
Article Synopsis
  • Cutaneous tuberculosis is a rare form of extra-pulmonary tuberculosis that can cause severe complications if not diagnosed and treated early, motivating a detailed study of its profile and outcomes in patients.
  • A study of 78 patients from August 2018 to 2022 found that 54 cases were confirmed with histopathology, revealing conditions like Lupus Vulgaris and scrofuloderma, with most patients showing improvement after 6 months of treatment.
  • The research highlights the importance of recognizing the disease to prevent misdiagnosis and related morbidity, emphasizing the need for heightened awareness among healthcare providers.
View Article and Find Full Text PDF

We describe a case of erythema induratum of Bazin (EIB) that presented recurrently on the extremities during treatment with anti-tuberculosis medications. The anti-tuberculosis medications were effective, so they were continued despite the occurrence of the EIB lesions, and those lesions disappeared 5 months after first appearing. EIB is currently considered a multifactorial disorder with many different causes, with tuberculosis being an example, and it is thought to be a hypersensitive immune response to .

View Article and Find Full Text PDF
Article Synopsis
  • Tuberculides are immune reactions to tuberculosis that occur in healthy individuals, and this study focuses on their characteristics and treatment responses in a North Indian healthcare center.
  • Analyzing clinical records from 2000 to 2019, the study identified 34 patients with tuberculides, with lichen scrofulosorum being the most prevalent type, followed by other forms like erythema nodosum.
  • The findings highlight that tuberculides can indicate hidden tuberculosis infections, aiding in early diagnosis and effective treatment with a standard six-month anti-tubercular therapy regimen.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!